|
2,123
|
| 17527 |
P. aeruginosa infection
|
|
increases_activity of
|
T3SS
|
|
| 17528 |
T3SS
|
|
increases_transport of
|
exoS
|
into the host cell
|
| 17534 |
T3SS
|
|
increases_transport of
|
exoT
|
into the host cell
|
| 17535 |
T3SS
|
|
increases_transport of
|
exoU
|
into the host cell
|
| 17536 |
T3SS
|
|
increases_transport of
|
exoY
|
into the host cell
|
|
15695491
|
Pseudomonas aeruginosa diseases
|
|
2,464
|
| 22795 |
P. aeruginosa infection
|
|
increases_activity of
|
T3SS
|
|
| 23018 |
T3SS
|
|
increases_transport of
|
exoU
|
into the host cell
|
| 23033 |
T3SS
|
|
increases_transport of
|
exoT
|
into the host cell
|
| 23034 |
T3SS
|
|
increases_transport of
|
exoY
|
into the host cell
|
| 23035 |
T3SS
|
|
increases_transport of
|
exoS
|
into the host cell
|
|
20947426
|
Pseudomonas aeruginosa diseases
|
|
2,586
|
| 24363 |
P. aeruginosa infection
|
|
increases_activity of
|
T3SS
|
in ameba, insect, zebrafish, and mammalian infection models
|
| 24364 |
T3SS
|
|
increases_transport of
|
exoS
|
into the host cell
|
| 24365 |
T3SS
|
|
increases_transport of
|
exoT
|
into the host cell
|
| 24366 |
T3SS
|
|
increases_transport of
|
exoU
|
into the host cell
|
| 24367 |
T3SS
|
|
increases_transport of
|
exoY
|
into the host cell
|
| 24368 |
T3SS
|
|
increases_transport of
|
fliC
|
into the host cell
|
| 24369 |
T3SS
|
|
decreases_activity of
|
phagocytosis
|
|
| 24371 |
Ca2+
|
|
affects_activity of
|
T3SS
|
|
| 24377 |
Type IV pili-dependent localized adherence to host
|
|
increases_activity of
|
T3SS
|
|
|
21833328
|
Pseudomonas aeruginosa diseases
|
|
2,592
|
| 24445 |
P. aeruginosa infection, acute
|
|
increases_activity of
|
T3SS
|
|
|
21955777
|
Pseudomonas aeruginosa diseases
|
|
2,595
|
| 24527 |
cdiGMP
|
|
decreases_activity of
|
T3SS
|
if c-di-GMP levels are increased
|
| 24555 |
wspR
|
|
decreases_activity of
|
T3SS
|
if wspR is overexpressed
|
| 24556 |
tpbB
|
|
decreases_activity of
|
T3SS
|
if PA1120 is overexpressed
|
| 24558 |
PA2133
|
|
increases_activity of
|
T3SS
|
if PA2133 is overexpressed
|
|
21955777
|
Pseudomonas aeruginosa diseases
|
|
2,621
|
| 24892 |
P. aeruginosa infection, acute
|
|
increases_activity of
|
T3SS
|
|
|
21264306
|
Pseudomonas aeruginosa diseases
|
|
2,742
|
| 25396 |
T3SS
|
NOT |
affects_expression of
|
BDKRB1
|
|
|
22092568
|
Pseudomonas aeruginosa diseases
|
|
2,763
|
| 25599 |
T3SS
|
|
increases_activity of
|
cell death
|
during lung infection; at a more rapid rate than T2SS (within 24 h)
|
|
21502078
|
Pseudomonas aeruginosa diseases
|
|
2,801
|
| 25846 |
T3SS complex
|
|
increases_activity of
|
T3SS
|
|
|
21479247
|
Pseudomonas aeruginosa diseases
|
|
2,853
|
| 26300 |
kinB
|
NOT |
affects_activity of
|
T3SS
|
|
|
21515773
|
Pseudomonas aeruginosa diseases
|
|
2,972
|
| 27086 |
Ca2+
|
|
affects_activity of
|
T3SS
|
|
|
21772833
|
Pseudomonas aeruginosa diseases
|
|
3,006
|
| 27370 |
T3SS
|
|
increases_transport of
|
exoS
|
in A459, BJAB, Jurkat, differentiated HL-60 and U937 cells
|
| 27371 |
T3SS
|
|
increases_transport of
|
exoY
|
in A459, BJAB, Jurkat, differentiated HL-60 and U937 cells
|
| 27372 |
T3SS
|
NOT |
affects transport of
|
exoS
|
in undifferentiated HL-60 or U937 cells
|
| 27373 |
T3SS
|
NOT |
affects transport of
|
exoY
|
in undifferentiated HL-60 or U937 cells
|
|
22299042
|
Pseudomonas aeruginosa diseases
|
|
3,015
|
| 27552 |
T3SS
|
|
affects_activity of
|
actin cytoskeleton organization
|
|
| 27553 |
T3SS
|
|
affects_activity of
|
host cell projection
|
|
|
19910414
|
Pseudomonas aeruginosa diseases
|
|
3,113
|
| 28603 |
exsA
|
|
increases_activity of
|
T3SS
|
|
| 28608 |
flagellum
|
|
decreases_activity of
|
T3SS
|
|
| 28620 |
gacA
|
|
decreases_activity of
|
T3SS
|
|
|
17307856
|
Pseudomonas aeruginosa diseases
|
|
3,156
|
| 29037 |
oprF
|
|
increases_activity of
|
T3SS
|
|
|
21189321
|
Pseudomonas aeruginosa diseases
|
|
3,202
|
| 29416 |
vfr
|
|
increases_activity of
|
T3SS
|
|
|
22354680
|
Pseudomonas aeruginosa diseases
|
|
3,206
|
| 29691 |
mucoid strain
|
|
decreases_activity of
|
T3SS
|
|
|
22354680
|
Pseudomonas aeruginosa diseases
|
|
3,442
|
| 32119 |
crc
|
|
increases_activity of
|
T3SS
|
|
|
20626455
|
Pseudomonas aeruginosa diseases
|
|
3,905
|
| 39664 |
pprB
|
|
decreases_activity of
|
T3SS
|
|
|
23209420
|
Pseudomonas aeruginosa diseases
|
|
3,941
|
| 39997 |
T3SS
|
NOT |
affects transport of
|
plpD
|
|
|
20192961
|
Pseudomonas aeruginosa diseases
|
|
3,953
|
| 40131 |
T3SS
|
|
increases_transport of
|
exoU
|
|
|
23481600
|
Pseudomonas aeruginosa diseases
|
|
3,961
|
| 40258 |
nitrate reductase complex, narGHI
|
|
increases_activity of
|
T3SS
|
|
| 40259 |
nirS
|
|
increases_activity of
|
T3SS
|
|
| 40266 |
NO
|
|
increases_activity of
|
T3SS
|
|
|
19651860
|
Pseudomonas aeruginosa diseases
|
|
4,439
|
| 44919 |
crc
|
|
increases_activity of
|
T3SS
|
analysing cell viability in infected Hela- and A549 cells
|
|
23292701
|
Pseudomonas aeruginosa diseases
|
|
4,505
|
| 45098 |
T3SS
|
|
increases_activity of
|
membrane bleb niche formation
|
|
| 45099 |
T3SS
|
|
increases_activity of
|
P. aeruginosa intracellular replication
|
in membrane bleb niches of epithelial cells
|
|
18316391
|
Pseudomonas aeruginosa diseases
|
|
4,601
|
| 45805 |
Kanamycin, subinhibitory level
|
|
decreases_activity of
|
T3SS
|
|
|
24260549
|
Pseudomonas aeruginosa diseases
|
|
6,386
|
| 60194 |
T3SS
|
|
increases_transport of
|
pemA
|
into the host cell
|
| 60195 |
T3SS
|
|
increases_transport of
|
pemB
|
into the host cell
|
|
25784698
|
Pseudomonas aeruginosa diseases
|
|
6,388
|
| 60197 |
T3SS
|
|
increases_transport of
|
ndk
|
into the host cell
|
|
24699069
|
Pseudomonas aeruginosa diseases
|
|
6,526
|
| 62069 |
T3SS
|
|
increases_transport of
|
fliC
|
|
| 62088 |
T3SS
|
|
increases_transport of
|
fliD
|
|
| 62096 |
T3SS
|
|
increases_transport of
|
flgK
|
|
| 62097 |
T3SS
|
|
increases_transport of
|
flgL
|
|
| 62098 |
T3SS
|
|
increases_transport of
|
flgE
|
|
| 62099 |
T3SS
|
|
increases_transport of
|
flgB
|
|
|
25845843
|
Pseudomonas aeruginosa diseases
|
HoPaCI